After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARQT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Arcutis Biotherapeutics Inc is $1.44B. A total of 4.92 million shares were traded on the day, compared to an average of 2.10M shares.
In the most recent transaction, Matsuda Masaru sold 8,338 shares of ARQT for 12.70 per share on Feb 03 ’25. After the transaction, the insider now owns 178,692 company shares. In a previous transaction on Feb 03 ’25, Watanabe Todd Franklin sold 19,301 shares at 12.70 per share. ARQT shares that the insider owns now total 804,129.
Among the insiders who sold shares, Welgus Howard G. disposed of 10,000 shares on Feb 03 ’25 at a per-share price of $12.71. This resulted in the Director holding 141,944 shares of ARQT after the transaction. In another insider transaction, Burnett Patrick sold 12,116 shares at $12.70 per share on Feb 03 ’25. Company shares held by the insider now total 114,862.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARQT has a high of $16.20 and a low of $6.05.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARQT’s latest balance sheet shows that the firm has $387.06M in Cash & Short Term Investments as of fiscal 2021. There were $77.56M in debt and $33.33M in liabilities at the time. Its Book Value Per Share was $1.34, while its Total Shareholder’s Equity was $297.68M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARQT is Buy with a score of 4.63.
